The integration of chemotherapy and surgery for bladder cancer Review uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Transitional Cell
  • Cystectomy
  • Urinary Bladder Neoplasms

abstract

  • Despite surgery with curative intent, approximately 50% of patients with muscle-invasive transitional cell carcinoma of the bladder will develop distant metastases and succumb to their disease. Attempts to improve outcomes have focused on refining surgical techniques and integrating perioperative chemotherapy. This review summarizes the available literature addressing the role of pelvic lymphadenectomy, neoadjuvant chemotherapy, and adjuvant chemotherapy in the management of patients with muscle-invasive transitional cell carcinoma of bladder.

publication date

  • January 2005

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 19813322

Additional Document Info

start page

  • 45

end page

  • 51

volume

  • 3

number

  • 1